Provided by Tiger Fintech (Singapore) Pte. Ltd.

NRX Pharmaceuticals Inc.

2.05
-0.0260-1.25%
Post-market: 2.120.0659+3.21%19:37 EDT
Volume:96.59K
Turnover:199.80K
Market Cap:34.74M
PE:-0.87
High:2.10
Open:2.09
Low:2.03
Close:2.08
Loading ...

NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
01 May

NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announces FDA Award of Filing Fee Waiver for Upcoming NRX-100 (Preservative Free Ketamine) New Drug Application to Treat Patients With Suicidal Depression

THOMSON REUTERS
·
30 Apr

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces FDA Award of Filing Fee Waiver for Upcoming NRX-100 (preservative free ketamine) New Drug Application to Treat Patients with Suicidal Depression

PR Newswire
·
30 Apr

NRX Pharmaceuticals Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
29 Apr

Psychedelic: Clearmind completes clinical site initiations for AUD trial

TipRanks
·
25 Apr

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics™, Inc.to Participate in an H.C. Wainwright @ Home Fireside Discussion on Tuesday, April 22, 2025

PR Newswire
·
21 Apr

BRIEF-Nrx Pharmaceuticals Inc - Increases Maximum Aggregate Offering Price Under Aug 14 2023 ATM Agreement To $20 Million - SEC Filing

Reuters
·
18 Apr

NRX Pharmaceuticals Inc - Increases Maximum Aggregate Offering Price Under Aug 14 2023 Atm Agreement to $20 Million - SEC Filing

THOMSON REUTERS
·
18 Apr

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Market Exclusive
·
07 Apr

BRIEF-Hope Therapeutics And Nrx Pharma Announce Signing Of A Term Sheet For Strategic Investment From A Global Medical Device Manufacturer

Reuters
·
03 Apr

Hope Therapeutics, Inc. and NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announce Signing of a Term Sheet for Strategic Investment From a Global Medical Device Manufacturer Into Hope

THOMSON REUTERS
·
03 Apr

NRX: Term Sheet Contemplates Investment of $2.5 Mln to Buy Series a Convertible Preferred Stock at $50 Mln Pre-Money Valuation

THOMSON REUTERS
·
03 Apr

Press Release: HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of a Term Sheet for Strategic Investment from a Global Medical Device Manufacturer into HOPE

Dow Jones
·
03 Apr

NRX Pharmaceuticals Initiated at Buy by BTIG

Dow Jones
·
02 Apr

BTIG Initiates NRX Pharmaceuticals With Buy Rating, $18 Price Target

MT Newswires Live
·
02 Apr

NRx Pharmaceuticals initiated with a Buy at BTIG

TIPRANKS
·
02 Apr

NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
31 Mar

Hope Therapeutics, Inc. and NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announce Definitive Purchase Agreement With Dura Medical; Initial Acquisition for Planned International Network of Interventional Psychiatry Clinics

THOMSON REUTERS
·
31 Mar

Press Release: HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Definitive Purchase Agreement with Dura Medical; Initial Acquisition for Planned International Network of Interventional Psychiatry Clinics

Dow Jones
·
31 Mar

NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
24 Mar